SYVC - Synovics Pharmaceuticals Inc
NYSE * Healthcare * Biotechnology
$0.00
+$0.00 (+0.00%)
About Synovics Pharmaceuticals Inc
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
SYVC Key Statistics
Market Cap
$0.54M
Revenue Growth
-0.8%
Profit Margin
-0.3%
Employees
155
How SYVC Compares to Peers
P/E Rank
N/A
of 5
Margin Rank
#6
of 6
Growth Rank
#6
of 6
Size Rank
#6
of 6
Synovics Pharmaceuticals Inc Company Information
- Headquarters
- 5360 Northwest 35th Avenue, Fort Lauderdale, FL, United States, 33309, undefined
- Sector
- Healthcare
- Industry
- Biotechnology